vimarsana.com
Home
Live Updates
Chroma Medicine Highlights Data Demonstrating Durable Multip
Chroma Medicine Highlights Data Demonstrating Durable Multip
Chroma Medicine Highlights Data Demonstrating Durable Multiplex Epigenetic Editing to Enhance Allogeneic CAR T at 65th ASH Annual Meeting
Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today presented data...
Related Keywords
Boston ,
Massachusetts ,
United States ,
San Diego ,
California ,
American ,
Vic Myer ,
Jamie Schafer ,
Prnewswire Chroma Medicine Inc ,
Twitter ,
Vivo Program Sciences ,
American Society Of Hematology ,
Linkedin ,
Enhance Allogeneic ,
American Society ,
Annual Meeting ,
Durable Multiplex Epigenetic Editing ,
Associate Director ,